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The proposal that dietary docosahexaenoic acid (DHA) enhances neurocognitive
functioning in term infants is controversial. Theoretical evidence, laboratory research and
human epidemiological studies have convincingly demonstrated that DHA deficiency can
negatively impact neurocognitive development. However, the results from randomized
controlled trials (RCTs) of DHA supplementation in human term-born infants have been
inconsistent. This article will (i) discuss the role of DHA in the human diet, (ii) explore
the physiological mechanisms by which DHA plausibly influences neurocognitive capacity,
and (iii) seek to characterize the optimal intake of DHA during infancy for neurocognitive
functioning, based on existing research that has been undertaken in developed countries
(specifically, within Australia). The major observational studies and RCTs that have
examined dietary DHA in human infants and animals are presented, and we consider
suggestions that DHA requirements vary across individuals according to genetic profile.
It is important that the current evidence concerning DHA supplementation is carefully
evaluated so that appropriate recommendations can be made and future directions of
research can be strategically planned.
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LC-PUFA IN THE CURRENT HUMAN DIET AND THE
IMPORTANCE OF DHA FOR EARLY BRAIN DEVELOPMENT
The omega-3 (n-3) long chain polyunsaturated fatty acid (LC-
PUFA), docosahexaenoic acid (DHA; 22:6 n-3), is involved
in several critical brain functions (Bradbury, 2011). DHA
accretes within the brain during gestation and the first year
of life during the “brain growth spurt” (Innis, 2008). During
this time, the developing brain is sensitive to extreme varia-
tions in the supply of DHA (Karr et al., 2011). DHA accre-
tion in the fetal brain can be influenced by maternal diet,
DHA stores, placental transport, and genetic polymorphisms
(McCann and Ames, 2010). Dietary DHA is obtained during
the postnatal period via breast milk or infant formula. The
concentration of DHA within breast milk can vary depending
on maternal DHA stores and diet (Innis, 2008). The average
DHA intake of Australian women during pregnancy and lacta-
tion is below global recommendations; this is likely to impact
the provision of DHA to the offspring (Bourre, 2007; Meyer,
2011).
Formula fed infants in many countries, including Australia,
may also be at risk of receiving insufficient dietary DHA, since
the inclusion of pre-formed n-3 and n-6 LC-PUFAs (including
DHA) in formula is not mandatory. It is argued that infants
are capable of synthesizing n-3 and n-6 LC-PUFAs endogenously
from their shorter chain precursors (Guesnet and Alessandri,
2011). However, there is considerable debate around human
capacity and ability to synthesize DHA. Research has found
single nucleotide polymorphisms (SNPs) in the fatty acid desat-
urase genes (FADS1 and FADS2) modulate individual capac-
ity for LC-PUFA synthesis (Glaser et al., 2011). Subsequently,
it is now recognized that dietary requirements for DHA and
other LC-PUFAs may vary across the population and are
somewhat dependent on individual genetic profile (Koletzko
et al., 2008). The need for LC-PUFA supplementation in term
infants therefore remains unknown. This article summarizes
the major animal studies and clinical trials pertaining to fatty
acid supplementation during infancy, and evaluates the cur-
rent level of evidence for LC-PUFA supplementation in term
infants.
The n-3 and n-6 families are distinct groups of PUFAs impor-
tant for human health, growth, and development. All PUFAs
within the n-3 family are derived from alpha linolenic acid (α-LA;
18:3 n-3), while all n-6 PUFAs are derived from linoleic acid (LA;
18:2 n-6). (Figure 1) The (short chain) parent molecules of the
n-3 and n-6 families, α–LA and LA, are described as “essential”
fatty acids, since humans and other mammals cannot synthesize
them endogenously (Kris-Etherton et al., 2000). The three most
biologically active members of these families are the LC-PUFAs:
DHA, eicosapentaenoic acid (EPA; 20:5 n-3) and arachidonic acid
(AA; 20:4 n-6). These three fatty acids all carry out separate,
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complex functional roles in the body (McNamara and Carlson,
2006).
For Western nations, low dietary intake of EPA and DHA is a
concern as these substances are not widely available in contem-
porary diets (Calder, 2012). There are few plant sources of DHA
and EPA, and they are found almost exclusively in oily, cold water
fish, fish oil supplements, breast milk, and supplemented infant
formula. α–LA is available in oils such as canola and soybean, as
well as in walnuts and flaxseed (Table 1). Converting α–LA into
EPA and DHA is a variable and inefficient process; stable-isotope
tracer studies have shown that dietary α-LA accounts for between
0.2 and 8% of EPA and <0.05 and 4% of DHA (Burdge and
Calder, 2005; Plourde and Cunnane, 2007). Similarly, less than
0.1% of LA is converted into AA. Furthermore, conversion lev-
els vary according to the intake of other fatty acids and the ratio
of n-6: n-3 PUFAs consumed in the diet (Bokor et al., 2010). n-6
PUFA intakes in Western diets are typically high, supplying ∼16
times more n-6 PUFA (including AA) than n-3 PUFA due to high
intakes of beef, pork, poultry, wheat germ, and various cooking
oils (Simopoulos, 2001b). In contrast, the diets of our paleolithic
ancestors are thought to have contained roughly equal ratios of
n-3: n-6 (Simopoulos, 2001a). Subsequently, there has been some
debate as to whether modern diets contain sufficient quantities of
n-3 fatty acids (in particular the n-3 LC-PUFAs, DHA and EPA)
to support optimum health across the lifespan, especially during
pregnancy and lactation (Eaton, 2000). It is possible that typi-
cal current levels of DHA intake are sufficient to achieve optimal
neurocognitive functioning in childhood. This is the focus of the
current review.
FIGURE 1 | The metabolic pathways involved in synthesizing n-6 and
n-3 long chain polyunsaturated fatty acids from their respective
shorter chain precursors.
DHAWITHIN THE BRAIN AFFECTS NEURONAL
DEVELOPMENT
There have been several lines of evidence that suggest that
LC-PUFAs (particularly DHA) are important for the function of
the CNS at the cellular and neurobiological level. The concentra-
tion of DHA and other LC-PUFAs within the brain can alter the
neuronal membrane fluidity and physical structure of neurons
(Youdim et al., 2000). n-3 and n-6 LC-PUFAs are also involved
in the production and activity of several neurotransmitters such
as dopamine and serotonin (Zimmer et al., 2002; Aid et al.,
2005; Chalon, 2006), affecting synaptic transmission and sub-
strate binding to membrane receptors (Horrocks and Farooqui,
2004). Furthermore, DHA has been shown to affect neural func-
tioning via its influence on gene expression in mammalian brain
tissue (de Urquiza et al., 2000; Kitajka et al., 2004). The pro-
cess of neurite outgrowth in hippocampal neurons is enhanced
by DHA, which may in turn promote learning (Calderon and
Kim, 2004) as the hippocampus is a critical brain region for
memory formation (Rolls, 2008; Berger et al., 2012). DHA may
also improve learning and memory through its role in the
development of pre- and post-synaptic proteins which enable
synaptic transmission and long-term potentiation (Cao et al.,
2009). It is apparent that DHA plays numerous important bio-
physical roles in brain structure and function, and has the
potential to influence neurocognitive development and subse-
quent performance (McNamara and Carlson, 2006; Parletta et al.,
2013).
During the last trimester of gestation and for the first 18
months after birth, AA, and DHA are deposited within the
cerebral cortex at a rapid rate (Martinez et al., 1974; Clandinin
et al., 1980). As noted above, this stage of human development is
known as the brain growth spurt (Martinez and Mougan, 1998),
when neuronal development is particularly vulnerable to nutri-
tional insufficiencies (Nyaradi et al., 2013). Further evidence from
studies on young non-human primates has revealed that once
brain DHA depletion has occurred it is physiologically difficult
to reverse (Ikemoto et al., 2001).
Table 1 | Common dietary sources of n-3 and n-6: short chain
essential fatty acids (α-LA and LA) and long chain polyunsaturated
fatty acids (DHA and AA) (Howe et al., 2006; Russo, 2009).
Omega-3 PUFA Omega-6 PUFA
Dietary
sources:
EFA
α-
LA
Vegetable oils:
linseed and canola
Flaxseed and
walnut
Fish: herring,
salmon, and tuna
Green leaves
LA Vegetable oils:
Corn, sunflower, and
safflower
Pork
Walnut, peanut, and
wheat
Fish: herring, salmon,
and tuna
Dietary
sources:
LC-
PUFA
DHA
&
EPA
Fish: herring,
salmon, trout, tuna,
and fish oil
supplements
Breast milk
AA Beef, pork, and poultry
Whole-grain wheat
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DIETARY RECOMMENDATIONS FOR DHA DURING
PREGNANCY AND THE NEONATAL PERIOD
Considering the rapid accretion of DHA into the brain dur-
ing the last trimester of pregnancy and into the first year of
life, it is important to consider whether optimal DHA intake
is occurring during this period. Numerous expert and govern-
ment authorities worldwide agree that dietary DHA require-
ments are increased during pregnancy and lactation when a
minimum of 200mg of DHA per day is recommended (Van
Elswyk and Kuratko, 2009). This dose can be achieved by eat-
ing 1–2 portions of fish per week or taking fish oil supple-
ments (Koletzko et al., 2008). Recent figures indicate that 91%
of Australian women are failing to meet DHA recommenda-
tions during pregnancy and lactation (Cosatto et al., 2010), with
similar trends noted in many other Western countries (Meyer,
2011). In Australia, the median daily intake of DHA during
pregnancy is ∼96mg per day, ranging from 8 to 632mg per
day across individuals (Cosatto et al., 2010). Since the dietary
intake and maternal stores of DHA during pregnancy are known
to be key determinants of infant blood DHA concentrations at
birth (Bourre, 2007), low DHA consumption by women eating
Western diets has prompted some concern for the neurological
and neurocognitive development of their offspring (Rogers et al.,
2013).
With respect to intake of DHA via breastfeeding, findings from
the 2010 Australian National Infant Feeding Survey have revealed
that while around 96% of Australian women initiate breastfeeding
after birth, there is a rapid decline in breastfeeding rates dur-
ing the weeks and months following birth (AIHW, 2011; Burns
et al., 2012). Despite international recommendations for exclu-
sive breastfeeding for the first 6 months postnatally (Kramer and
Kakuma, 2001), in Australia an average of only 56% of women
breastfeed for this recommended amount of time (AIHW, 2011).
Moreover, the concentration of DHA within women’s breast
milk appear to be decreasing over time (Makrides et al., 1995).
A comprehensive analysis of human breast milk LC-PUFA com-
positions have revealed the current worldwide average DHA
concentration is approximately 0.32% of total fatty acids (TFA)
(Brenna et al., 2007). This corresponds to ∼60mg of DHA per
day for the first 6 months postnatally, assuming an average breast
milk intake of 750mL per day (Cunnane et al., 2000). Analysis
of Australian breast milk concentrations in 1981 and 1993 found
that the amount of DHA decreased by 27% over this time period
while concentrations of AA remained the same (Makrides et al.,
1995). A similar decline in humanmilk DHA has been reported in
a Canadian population (Innis, 2003). The decline in breast milk
DHA may plausibly be explained by dietary shifts over time, the
use of different FA analytical techniques (Makrides et al., 1995)
or through differences in maternal FADS genotype across studies
(Xie and Innis, 2008; Moltó-Puigmartí et al., 2010)—an issue that
will be discussed further below.
Formula-fed infants may also be at risk of sub-optimal DHA
supply during this period. DHA brain content has been ana-
lyzed in autopsy studies of human infants conducted in Australia
(Makrides et al., 1994) and the United Kingdom (Farquharson
et al., 1995). Both studies found that the brain tissue of breast-
fed infants contained higher concentrations of DHA compared
to their standard formula-fed counterparts. These findings are
consistent with animal studies, where dietary restriction of n-3
PUFA decreased the amount of DHA within the brain (Diau
et al., 2005; Brenna, 2011; Luchtman and Song, 2013). One of the
compelling arguments for including DHA and other LC-PUFAs
in infant formula is to render its composition more similar to
breast milk, which is commonly cited as the “gold standard” for
infant nutrition (Burns et al., 2012). DHA enriched formula can
enable formula-fed infants to attain DHA levels that are equiva-
lent to their human milk receiving counterparts (Cunnane et al.,
2000). However, clear functional benefits to infant development
need to be demonstrated before DHA enriched formula can be
unequivocally recommended.
THE FUNCTIONAL EFFECTS OF DHA ON NEUROCOGNITION:
EVIDENCE FROM STUDIES OF DEFICIENCY IN ANIMALS
The evidence that DHA deficiency is detrimental to neurocog-
nitive development is well established in animal models. The
functional consequences of lower DHA concentrations within the
CNS in baboons include visual (Neuringer et al., 1986) andmotor
deficits (Champoux et al., 2002). Studies have found that n-3
PUFA deficient rodents exhibit poorer performance in the Morris
water maze test compared to their n-3 PUFA-sufficient counter-
parts (Sheaff et al., 1999; Moriguchi et al., 2000; Lim et al., 2005).
DHA deficient mice exhibit a range of neurocognitive impair-
ments, including problems with learning and memory (Catalan
et al., 2002) and can have a heightened stress response (Fedorova
and Salem, 2006). Detailed reviews in this area have been con-
ducted by Davis-Bruno and Tassinari (2011) and Luchtman and
Song (2013).
Animal studies allow more flexibility with respect to study
design and potentially offer greater insight into the neurologi-
cal mechanisms influenced by DHA deficiency in human infants
(Romijn et al., 1991). However, there are limitations in the extrap-
olation of findings obtained in animal studies to the study of
nutrition in humans. Research undertaken in non-human pri-
mates offers certain advantages over rodent studies in terms
of transferability to humans, related to similarities in relative
brain size, retinal microarchitecture and other anatomical, phys-
iological and genealogical homologies (Brenna, 2011). However,
human neurocognitive functioning is more complex and relies to
a greater degree on higher cognitive capacities such as language
and executive functioning (Luchtman and Song, 2013). A degree
of caution should be applied when generalizing findings from
animals to humans (Innis, 2007). Nonetheless, there is a strong
and consistent body of evidence obtained from animal studies
linking n-3 LC-PUFA deficiency to impaired neurocognitive func-
tions. These links warrant further investigation through clinical
research in humans.
MATERNAL DIETARY DHA INTAKE AND SUPPLEMENTATION
Epidemiological studies of maternal DHA intake provide insight
into the potential value of DHA on neurocognitive outcomes.
A very large observational study (n = 11, 875) in pregnancy
found a significant association between low maternal seafood
consumption (<340 g per week) and suboptimal neurocogni-
tive outcomes in childhood (Hibbeln et al., 2007). Children aged
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6 months to 8 years whose mothers consumed low seafood
diets during pregnancy had lower verbal IQ, displayed less pro-
social behavior (defined as voluntary behavior intended to benefit
another) and had poorer social and communication skills com-
pared to those whose mothers consumed high seafood diets
(Hibbeln et al., 2007). Furthermore, in a study of Canadian Inuit
people (who typically consume a DHA-rich diet) DHA concen-
trations in umbilical cord plasma were positively associated with
longer gestation, better visual acuity, higher scores of novelty pref-
erence on the Fagan test at 6 months and higher cognitive scores
on the BSID-II of mental and psychomotor performance at 11
months (Jacobson et al., 2008). Most published observational
epidemiological studies have recognized a positive association
between maternal intake of n-3 LC-PUFA rich foods during preg-
nancy and neurocognitive development of offspring (Oken et al.,
2005, 2008; Hibbeln et al., 2007; Mendez et al., 2009; Boucher
et al., 2011). The observational study by Gale et al. (2008), how-
ever, detected no association between the frequency with which
mothers ate fish in pregnancy and full-scale or performance IQ of
their offspring at 9 years of age. Nevertheless, these researchers did
find that children whose mothers had eaten oily fish had higher
verbal IQ and a reduced risk of hyperactivity compared to those
children whose mothers did not eat oily fish, after adjustment
for potential confounding factors. However, the findings of these
studies are somewhat weakened due to potentially confounding
variables, including social and economic differences that may
independently affect neurodevelopmental outcomes in childhood
(Drane and Logemann, 2000; Boyd et al., 2013).
It is well established that maternal fish oil supplementation
during pregnancy substantially increases fetal DHA concentra-
tion at the time of birth (Larqué et al., 2012). Furthermore, two
randomized controlled trials (RCTs) have shown that DHA sup-
plementation during pregnancy offers significant benefit to infant
neurocognitive development (Judge et al., 2007; Dunstan et al.,
2008). However, the RCTs in this area are not easily compara-
ble and positive effects have not been identified in all studies (Lo
et al., 2012). One long term follow-up found that maternal sup-
plementation enhanced neurocognitive outcomes up to 4 years
later (Helland et al., 2003) but the effect did not persist after 7
years (Helland et al., 2008). A relatively large RCT (n = 249) from
Bangladesh found that maternal DHA supplementation from 25
weeks gestation until delivery had no effect on infant BSID-II
mental and psychomotor performance outcomes at 10 months
(Tofail et al., 2006). Such findings may not be directly comparable
to an Australian population since maternal nutrition and anthro-
pometric status in developing countries are often low (Karim and
Mascie-Taylor, 1997; Dhar et al., 2003). It is also possible that the
control oil used in this study (which contained α-LA: 2700mg and
LA: 2250mg per day) may have inadvertently promoted infant
neurocognitive status, thereby attenuating any treatment effect
from the intervention (Tofail et al., 2006).
A meta-analysis and systematic review of maternal n-3 LC-
PUFA supplementation undertaken by Gould et al. (2013) high-
lighted numerous potential areas of bias in the current literature
and remarked on the relatively poor quality of most RCTs in this
field. Of major concern was the consideration that publications
seldom reported the randomization process and/or method(s)
used to conceal treatment allocation from participants. According
to this review, the only RCT of maternal DHA supplementation
and infant neurocognitive outcomes that was considered to be
genuinely free from bias was conducted in Australia by Makrides
et al. (2011a). This RCT found no significant association between
moderate DHA supplementation (800mg per day) during preg-
nancy and BSID-II scores of language or cognitive development
at 2½years (n = 2399). However, this RCT revealed that children
in the treatment groupmanifested significantly lower incidence of
cognitive delay compared to their un-supplemented counterparts.
In summary, RCTs and epidemiological studies evaluating the
potential neurocognitive impact of maternal DHA supplemen-
tation during pregnancy have revealed somewhat heterogeneous
results in healthy term infants. Consequently, it may be premature
tomake unequivocal recommendations about any neurocognitive
benefits of DHA supplementation in healthy term infants based
on the currently available research findings.
CORRELATIONS BETWEEN INFANT NEUROCOGNITION AND
BREASTFEEDING
Over the years, many prospective observational studies have indi-
cated that breastfed infants have a significant neurocognitive
advantage over their formula fed counterparts (Anderson et al.,
1999; Agostoni et al., 2001; Oddy et al., 2003, 2011; Kramer et al.,
2008). It has been theorized that this is due to the higher pres-
ence of DHA in breast milk, relative to formula milks. Some
studies have found positive associations between DHA concen-
trations within breast milk and/or infant blood levels and better
outcomes of visual acuity (Innis et al., 2001; Jørgensen et al.,
2001). However, it is likely that breastfeeding enhances infant
development due to a number of inter-related factors as reviewed
in Jain et al. (2002). Specifically, observational studies are poten-
tially confounded by the heterogeneous composition of breast
milk (both within and between lactating individuals), environ-
mental factors such as maternal/infant bonding and other influ-
ences (Jain et al., 2002). One particularly significant potentially
confounding factor is social economic status (SES), which is
positively associated with both maternal and infant IQ, along
with the decision to breastfeed (Der et al., 2006; de Jager et al.,
2013). Furthermore, the breastfeeding act itself may be indicative
of maternal attentiveness and nurturing which may indepen-
dently foster long term positive effects on infant neurocognitive
outcomes (Morley et al., 1988). Despite appropriate statistical
techniques used to try to control for the influence of confounders,
observational studies can be subject to systematic bias and results
should therefore be interpreted with some caution.
A study by Caspi et al. (2007) tested the association between
breastfeeding and child IQ with respect to FADS2 genetic pro-
file, specifically in terms of the SNP rs174575. Breastfed infants
who were rs174575 C-dominant carriers achieved higher scores
on standardized IQ tests compared to the C-carriers who were not
breastfed. Meanwhile, children homozygous for the minor allele
(GG genotype) were found to have similar IQs, irrespective of
feeding method. These findings remained statistically significant
after accounting for potential confounding variables including
intrauterine growth, family social economic status, and mater-
nal cognitive ability. While potentially important in terms of the
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possible interaction between breastfeeding and the genetic sta-
tus of the infant, these findings have yet to be replicated by other
research studies.
CORRELATIONS BETWEEN INFANT NEUROCOGNITION AND
DHA STATUS
Many trials have found that higher plasma or RBC DHA concen-
trations (often as a result of LC-PUFA supplementation) are pos-
itively correlated with infant neurocognitive outcomes (Agostoni
et al., 1995, 1997; Gibson et al., 1997; Birch et al., 2000; Innis
et al., 2001; Helland et al., 2003; Innis, 2003; Jensen et al., 2005;
Drover et al., 2011). Some studies, on the other hand, have found
no significant relationships (Lucas et al., 1999; Makrides et al.,
2000; Auestad et al., 2001), while conversely two studies have
found that higher infant DHA blood concentration has a negative
neurocognitive effect (Scott et al., 1998; Lauritzen et al., 2005).
It should be cautioned that associations between DHA status
and infant neurocognitive status do not necessarily demonstrate
causality, nor do they demonstrate the effectiveness of the inter-
vention alone—as this may be confounded by other nutrients
(Innis, 2003).
RCTs OF LC-PUFA SUPPLEMENTATION IN TERM AND
PRETERM POPULATIONS
In order to confirm whether dietary LC-PUFA is responsible for
the enhanced neurocognitive outcomes associated with breast-
feeding and higher DHA status, RCTs of LC-PUFA supplemen-
tation are necessary. Several of these trials have been conducted,
usually in formula-fed infants. The most common methodology
involves comparing the neurodevelopmental outcomes of infants
randomized to receive infant formula with DHA (either alone or
in combination with AA and/or other PUFAs) or placebo (un-
supplemented formula). The majority of trials in healthy term
infants have shown little or no consistent, beneficial effects on
neurocognitive outcomes as a result of dietary LC-PUFA sup-
plementation. However, infant LC-PUFA supplementation has
resulted in no negative effects on growth, development or mor-
bidity (Koletzko et al., 2005). There is, therefore, currently no
compelling argument either for or against LC-PUFA supplemen-
tation in term infants with respect to neurocognitive outcomes.
This conclusion has been re-iterated in three consecutive versions
of the Cochrane review (Simmer, 2001; Simmer et al., 2008, 2011)
that have evaluated 9, 14, and 15 relevant RCTs, respectively.
Interestingly, in the authors’ conclusions for both the (2008) and
(2011) Cochrane reviews, Simmer et al. refer to the positive results
found by the Dallas group (Birch et al., 2005) and state that these
results need to be replicated in other settings. These authors also
propose that future RCTs should explore the use of DHA derived
from single cell microalgae and supply higher doses of DHA,
in line with typical human milk (DHA 0.32%) concentrations
throughout the world.
Hoffman et al. (2009) reviewed 20 RCTs within this field
including several studies not included in the Simmer et al. (2008)
Cochrane review and elaborated on some methodological fac-
tors including dosage, source, and duration of supplementation.
Hoffman et al. (2009) concluded that trials which supplied term
infants with DHA in concentrations greater than 0.3%TFA (in
addition to AA >0.3%TFA) were more likely to identify a signif-
icantly positive effect on neurocognitive and visual outcomes. In
another meta-analysis utilizing individual patient data (IPD) with
a considerable sample size (n = 870), Beyerlein et al. (2010) com-
bined the raw scores from four methodologically similar RCTs
(Lucas et al., 1999; Fewtrell et al., 2002, 2004; Bouwstra et al.,
2005) which each assessed BSID-II outcomes at 18 months. The
analysis concluded that LC-PUFA supplemented formula con-
veys no significant benefit on neurodevelopment at 18 months,
as assessed using the BSID-II. However, this meta-analysis was
unable to access IPD from all relevant trials (Birch et al., 2000;
Clandinin et al., 2005).
Evidence that infant DHA supplementation conveys signifi-
cant benefit on visual acuity is derived from a systematic review
of 12 clinical studies from the Harvard School of Public Health
(SanGiovanni et al., 2000). SanGiovanni et al. (2000) incorpo-
rated the results from both randomized and non-randomized
studies of DHA supplemented formula and concluded that
increased dietary DHA improved visual acuity in term infants
at two and four months of age. It should be cautioned that
analyses that combine findings from both randomized and non-
randomized trials have a higher risk of incorporating selection
bias in the recruitment for the trial (Szajewska, 2011). More
recent reviews in this field suggest that more research is required
before definitive recommendations can be made concerning
whether term infants would benefit from n-3 LC-PUFA supple-
mented formula (Agostoni, 2008; Benton, 2008; Belkind-Gerson
et al., 2008; Makrides et al., 2011b; Campoy et al., 2012).
The majority of RCTs of infant DHA supplementation (as
described above) use infant formula and are constrained by the
consideration that their study samples have chosen not to breast-
feed, thereby reducing external validity of the findings (Gibson
and Makrides, 1998; Smithers et al., 2008a). There have been a
small number of studies which have supplemented infants with
DHA directly, thereby bypassing the need to employ formula-
based supplementation. To the best of our knowledge, only one
such direct supplementation RCT has addressed the effect of
DHA on infant neurocognitive functioning (Meldrum et al.,
2012). In this recent double-blinded, placebo-controlled trial
conducted in Australia (Meldrum et al., 2012), healthy term
infants (n = 287) were randomized to either very high dose fish
oil (incorporating >250mg DHA plus 60mg EPA) or placebo
(olive oil) per day from birth to 6 months. The study determined
that while infants within the fish oil group had significantly higher
DHA concentrations in erythrocyte and plasma phospholipids
at 6 months of age relative to the placebo group, there was no
significant difference between standard or composite scores of
the BSID-III (third edition) at 18 months or on outcomes from
the Child Behavior Checklist. In a subtest which explored the
development of infant communication skills (n = 185), the study
found that scores for later developing gestures and total number
of gestures were significantly higher in the fish oil group com-
pared to the placebo group at both 12 and 18months. This finding
is interesting since gestural skills in infancy are associated with
visual recognition memory, deferred imitation and turn-taking
skills (Heimann et al., 2006). Furthermore, these skills are under-
stood to predict language and communicative ability in later life
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(Acredolo and Goodwyn, 1988). Direct supplementation of the
oil emulsion allowed participation of breast- and/or formula-fed
infants alike. However, a potential criticism of this study is that
the odor of the fish oil may not have been adequately masked, and
therefore parents were frequently able determine which treatment
their child was receiving. This, in turn, may have affected parents’
ratings of their child’s gestural abilities.
While the focus of the current paper is on term infant
neurocognitive response to DHA supplementation, valuable
information can be gleaned from investigation into the preterm
population. Preterm infants are especially vulnerable to DHA
deficiency as they have not had access to maternal lipid stores for
the normal period of gestation (Haggarty, 2002). Similar to full
term infants, preterm infants fed formulamilk without DHA have
lower DHA status compared to those fed human milk (Carlson
et al., 1986) or LC-PUFA supplemented formula (Koletzko et al.,
1989; Lapillonne et al., 2000). It has been identified that children
born preterm have higher rates of learning disabilities, language
impairment, attention deficits, hyperactivity, and reduced cogni-
tive test scores compared to (gender- and age-matched) children
born at term (Bhutta et al., 2002; Perricone and Morales, 2011).
Although there are many factors associated with preterm deliv-
ery, it is possible that lower DHA status during the critical period
of brain growth may contribute toward impaired neurocognitive
development (McNamara and Carlson, 2006).
The DINO (DHA infant neurodevelopmental outcomes)
double-blind RCT provided supplementation to lactating moth-
ers (n = 657) in order to increase breast milk DHA (Makrides
et al., 2009). Lactating women were either supplied six 500mg
DHA-rich tuna oil capsules per day or placebo soy oil cap-
sules. Mothers were encouraged to breastfeed; however, if the
mother chose not to provide breast-milk or if additional milk was
required, infant formula was provided. The DHA concentrations
of the formula matched the typical milk DHA concentrations of
the two groups. The study found that preterm infants in the DHA
group had better visual development (as determined through
sweep VEP acuity) at 4 months corrected age [i.e., chronologi-
cal age corrected for the degree of prematurity; (Smithers et al.,
2008b)]. A higher mean mental development index of children in
the DHA supplemented group (as assessed using the BSID-II) was
found. However, after adjusting for confounding factors this ben-
efit was not statistically significant (p = 0.2). Yet the number of
children in the DHA group with low cognitive scores (indicative
of mildly delayed development) was significantly smaller in the
treated group compared with the control group. In pre-planned
secondary analyses, the DINO study found DHA supplementa-
tion had a significantly positive effect on cognitive outcomes in
girls compared to boys. The reason for differences in response
to DHA as a function of gender remains unclear but may be
related to the higher rate of LC-PUFA synthesis that has been
identified in females (Burdge and Nagura, 2002). The authors
proposed that the dose of DHA chosen for this study may not
have been sufficient to elicit equivalent neurocognitive benefits
in males and they considered whether enhancing DHA concen-
trations may evoke neurocognitive advantages (Makrides et al.,
2009). Furthermore, the authors concluded that the DHA con-
centration in standard human breast milk of Australian women
is sub-optimal for the visual development of preterm infants
(Smithers et al., 2008b).
There have been numerous LC-PUFA supplementation tri-
als in preterm infants which have reported greater visual acu-
ity following enhanced dietary DHA relative to placebo (Birch
et al., 1992; Carlson et al., 1993; Smithers et al., 2008b).
Similarly, numerous RCTs in preterm populations have found
that DHA supplementation positively affects neurocognitive out-
comes including language comprehension (O’Connor et al.,
2001), memory (Henriksen et al., 2008) and mental and psy-
chomotor development (Clandinin et al., 2005). However, the
review by Qawasmi et al. (2012) points out that there are also
many RCTs which have consistently shown no neurocognitive
effect, both in preterm and term infant populations. Similarly,
Schulzke et al. (2011) concluded that there is insufficient evidence
to recommend DHA supplementation with respect to routine
neonatal care in preterm infants. The most recent Cochrane
review of LC-PUFA supplementation of preterm formula con-
cludes that there are no clear long-term benefits on visual or
intellectual development after pooling data across studies of
preterm infants (Schulzke et al., 2011). Finally, two recently pub-
lished reviews reflect uncertainty as to whether preterm infants
should be supplemented with dietary DHAwith respect to poten-
tial long term neurocognitive or developmental benefits (Molloy
et al., 2012; Lapillonne et al., 2013). Further investigation is
clearly warranted concerning the role of DHA supplementation in
modulating optimal neurocognitive outcomes in preterm infant
populations.
GENETIC FACTORS MODULATING INDIVIDUAL DIETARY
REQUIREMENTS FOR n-3 LC-PUFAs
A relatively new area of investigation concerns how genetic dif-
ferences may modulate individual LC-PUFA requirements. Such
research has focused on the genes FADS1 and FADS2. These genes
are known to act upon the enzymes delta-5 desaturase (D5D)
and delta-6 desaturase (D6D) and influence the efficiency with
which shorter chain n-3 and n-6 PUFAs are converted into LC-
PUFA products (Nakamura and Nara, 2004; Schaeffer et al., 2006;
Rzehak et al., 2009; Bokor et al., 2010; Glaser et al., 2011). The
D5D and D6D enzymes are present in the human liver from early
gestation (Innis, 2005). The fetus is capable of synthesizing n-
3 LC-PUFAs from shorter chain n-3 precursors from 26 weeks
gestation (Uauy et al., 2000).
SNPs within FADS1 and FADS2 have been associated with the
ratio of desaturation precursors (i.e., α-LA, LA, eicosadienoic acid
(EDA; 20:2 n-6) and dihomogamma linolenic acid (DGLA; 20:3
n-6) to desaturation products, including the LC-PUFAs (EPA,
DPA, and AA) (Schaeffer et al., 2006; Gillingham et al., 2013).
In a very large German study conducted in an adult population,
the authors found that up to 28% of AA variability was associated
with 11 common SNPs (and 5 SNPs of reconstructed haplotypes)
from the FADS1 and FADS2 gene clusters (Schaeffer et al., 2006).
Yet, the FADS polymorphisms tested by Schaeffer et al. (2006)
could only explain ∼7% of EPA and 3% of DHA levels. Few
subsequent studies have been able to identify a significant asso-
ciation between FADS polymorphisms and DHA concentrations
in human populations (Koletzko et al., 2011; Lattka et al., 2013).
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However, Koletzko et al. (2011) identified significant associations
between fetal and maternal FADS genotypes and DHA concen-
trations in fetal circulation, irrespective of maternal diet. While it
currently appears that DHA concentrations are primarily modu-
lated though dietary supply, several FADS genetic polymorphisms
are still under investigation internationally (Glaser et al., 2011;
Gillingham et al., 2013) and are currently being considered in our
laboratory.
INTERPRETING CURRENT RESEARCH FINDINGS
Inconsistent findings within this literature have been the subject
of much consideration. suggestions as to why discrepancies may
have occurred are outlined in the review published by Meldrum
et al. (2011). Previous studies were identified as having consider-
able variability in: (i) inadequate sample sizes, (ii) doses of DHA
utilized, (iii) source of DHA used (i.e., algal or fish sources),
(iv) age at which supplementation was initiated, (v) duration
of supplementation, (vi) type of neurocognitive/developmental
assessments used to evaluate neurocognitive functioning, and
(vii) variability in participant compliance across studies. It was
also speculated in this review that genetic polymorphisms might
represent a potentially relevant factor affecting the outcomes of
these RCTs. It is now recognized that dietary requirements for
DHA and other LC-PUFAs may be somewhat heterogeneous
across individuals; for example, being somewhat dependent on
an individual’s genetic profile (Koletzko et al., 2011).
In addition to FADS genetic considerations, the lack of consis-
tency across RCTs of DHA supplementation may also be due, at
least in part, to gender based differences in LC-PUFAmetabolism
from shorter chain precursors (Guesnet and Alessandri, 2011). It
is known that the capacity to convert α-LA into n-3 LC-PUFAs
including DHA is significantly greater in females than in males
(Burdge, 2004), resulting in higher DHA circulating plasma con-
centration in females (Giltay et al., 2004). This is thought to be
due to the influence of estrogen and other hormones on the activ-
ity and expression of D5D andD6D in the liver (Extier et al., 2010;
Decsi and Kennedy, 2011). Evidence from the Western Australian
pregnancy cohort (Raine) study (n = 1038) has also found long
term neurocognitive benefits from breastfeeding to be gender spe-
cific (Oddy et al., 2011). This study found that breastfeeding had a
more pronounced neurocognitive benefit on male infants, as evi-
dent until 10 years of age (Oddy et al., 2011). A gender specific
response to DHA enriched human breast milk was also observed
by Makrides et al. (2009) in the aforementioned DINO study of
preterm infants. Females manifest a greater capacity for LC-PUFA
synthesis (Burdge and Nagura, 2002), such that males may have
higher dietary DHA requirements during infancy (Makrides et al.,
2009).
CONCLUSIONS AND FUTURE DIRECTIONS
DHA is known to play a critical role in the developing human
brain and there is evidence of its neurobiological importance
during infancy (McCann and Ames, 2005). DHA deficiencies in
animals have proven to exert deleterious effects on a range of
neurodevelopmental outcomes (McNamara and Carlson, 2006).
High intake of oily fish during pregnancy appears to benefit chil-
dren’s neurocognitive development. Additionally, several studies
have demonstrated positive associations between infant blood
concentrations of DHA and neurocognitive status (Innis, 2003,
2007). Yet previous RCTs undertaken in this field provide con-
flicting evidence concerning the putative neurocognitive benefits
of n-3 LC-PUFA supplementation in healthy full term infants.
Despite the consideration that the majority of RCTs report little
or no effect from supplementation (as cited in several Cochrane
reviews andmeta-analyses), many researchers suggest that further
work should be undertaken in order to better define optimal DHA
intakes before and during infancy.
It is possible that DHA deficiency during critical periods of
brain growth and structural organization may render the brain
vulnerable to neurological or neurodegenerative diseases later in
life (Farquharson et al., 1995). The development of the brain’s
architecture prenatally and during infancy lays down the foun-
dation on which the structure of the adult brain is based. It is
therefore possible that early modification of LC-PUFA levels will
have long-term structural and functional consequences which
may be too long-term and/or subtle to detect in healthy infants
and children (McNamara and Carlson, 2006). However, more
noticeable effects may emerge in older individuals. In this context,
the equivocal findings obtained in this field to date are heuris-
tic, as they will stimulate further research which should more
rigorously control for the potentially confounding variables that
have been identified in this review. As proposed by Alderson and
Roberts (2000), inconclusive results are potentially very informa-
tive in biomedical science as they stimulate further inquiry and
ultimately improve health outcomes for future generations.
While RCTs are generally thought to provide the most
robust indexes of causal mechanisms in human clinical research
(Szajewska, 2011), the results from observational studies in
humans and intervention studies in laboratory animals also
deserve serious consideration. In future, larger and higher dose
RCTs should be undertaken using more sensitive measures
of infant and child neurocognitive capacity. A more careful
approach to the design and analysis of observational epidemio-
logical studies is also likely to yield tangible benefit (for example,
through undertaking larger studies which are able to consider a
wider range of potentially confound variables).
Debate about the usefulness of dietary DHA during infancy
has been ongoing for over 30 years and a wealth of data have
been collected by research groups around the world. It would
be of far-reaching benefit for more international collabora-
tion to be undertaken within this area of inquiry. Data access
facilitated through computational platform/s that enable shar-
ing of de-identified, IPD could provide researchers with the
means to carry out statistically novel methods of data inter-
pretation on a very large scale. Meta-analysis of IPD allows
researchers to analyze the raw data of relevant original studies
(using similar covariates) and thereby derive potentially more
reliable conclusions (Stewart and Parmar, 1993). To the best
of our knowledge, only one IPD meta-analysis on the neu-
rocognitive effects of LC-PUFA supplementation during infancy
has been conducted (Beyerlein et al., 2010). This meta-analysis
was able to access the raw data from 4 out of the 6 rele-
vant RCTs. The limitations imposed on this IPD meta-analysis
by the non-availability of data from two relevant RCTs could
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be prevented in future if guidelines and policies are imple-
mented within a collaborative international scientific frame-
work that is more sensitive to ethico-legal and data-ownership
issues.
Despite the absence of a scientific consensus with regard
to putative benefits (as identified in this review), many man-
ufacturers of infant formula include DHA and AA in certain
formulations andmarket them as “superior products” which pro-
vide a distinct neurocognitive advantage (Simmer et al., 2011).
This shaping of public opinion through retail is controversial,
considering that there is little concrete scientific evidence to sup-
port these claims. Australia is one of the leading markets for n-3
products and supplements and, consequently, consumers are at
increased risk of being misled by current marketing approaches
(McManus et al., 2011). It is important for future research to
address these claims definitively, so as to either avoid unneces-
sary supplementation of infants’ diets (and the associated eco-
nomic cost) or to ensure that infants are universally provided
with adequate dietary DHA to prevent suboptimal neurocognitive
development.
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